FDA warns API manufacturer, OTC maker for sloppy GMP oversight

Regulatory News

Regulatory NewsJoanne S. Eglovitch

APIsAudit/inspectionComplianceNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy